EOM 1352: Fri 7 June 2024, 11:36

Current Edition

ramusmedical
Asia Pacific

Live from CPhI Japan 2017: Japanese pharma companies predict a 17% growth in 2017

CPhI research shows that the biologics and generics sector are driving growth over the next year Tokyo, 21st April 2017: CPhI Japan – organised by UBM EMEA and UBM As...
Continue Reading →
Connect with Aptar Pharma at RDD Europe 2017 – April 25-28 in Antibes, France
Europe

Connect with Aptar Pharma at RDD Europe 2017 – April 25-28 in Antibes, France

Louveciennes, France, April 24, 2017. Aptar Pharma is delighted to welcome delegates to RDD Europe 2017, which we’ve co-organized with RDD Online since 2005. In addit...
Continue Reading →
PCI Clinical Services Announces Additional Cryogenic Storage Capacity at Rockford, IL Facility
Europe

PCI Clinical Services Announces Additional Cryogenic Storage Capacity at Rockford, IL Facility

PCI Clinical Services (PCI) are pleased to announce a second phase 400 percent increase in Cyrogenic storage capabilities at our Rockford, Illinois site. The announc...
Continue Reading →
Regional News

CRF Health Recognized as a Finalist in 2016 Scrip Awards

TrialConsent™ solution named in ‘Best Technological Development’ category   Plymouth Meeting, PA – September 15, 2016: CRF Health, the leading global provider of eCOA...
Continue Reading →
Europe

Exco InTouch appoints Industry Veteran Steve Powell as Chief Operating Officer

14 September 2016 – Exco InTouch, the leading provider of digital patient engagement and data capture solutions for clinical research and healthcare providers, today ...
Continue Reading →
Europe

Ajaz Hussain and Wuxi Apptec’s Dr Minzhang Chen join 12 strong CPhI Annual Industry report experts

2016 report topics include 3D printing, FDA quality metrics, contract services, pharma growth in China and India, and generic licensing   The CPhI Expert Panel m...
Continue Reading →
Portola touts new data on recently rejected Xarelto, Eliquis antidote
Regional News

Portola touts new data on recently rejected Xarelto, Eliquis antidote

Earlier this month, Portola Pharmaceuticals took a hit when the FDA swatted down its reversal agent candidate for next-gen anticoagulants--and the makers of those ant...
Continue Reading →
Phase III trial flop scuttles Vectura’s hopes for expanding Flutiform into COPD
Europe

Phase III trial flop scuttles Vectura’s hopes for expanding Flutiform into COPD

Respiratory player Vectura can set aside its hopes of snagging a new COPD indication for its combination med Flutiform--at least for now. Tuesday, the U.K. company sa...
Continue Reading →
Roche’s Tecentriq steps up to challenge Keytruda, Opdivo with new lung cancer data
Europe

Roche’s Tecentriq steps up to challenge Keytruda, Opdivo with new lung cancer data

Roche’s Tecentriq appeared on the immuno-oncology scene in May of this year, approved to treat bladder cancer and trailing Merck’s Keytruda and Bristol-Myers Squibb’s...
Continue Reading →
North America

Worldwide Clinical Trials Appoints Miroslav Backonja as Senior Medical Director

MORRISVILLE, NC, SEPTEMBER 1, 2016 – Worldwide Clinical Trials (www.worldwide.com) has appointed Miroslav Backonja, M.D., as Senior Medical Director of Neuroscience, ...
Continue Reading →
Quotient